Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nitrilase family member 2 (NIT2) is a mammalian enzyme and member of the nitrilase superfamily, a group of thiol enzymes that catalyze hydrolysis of C-N bonds. NIT2, also known as nitrilase-2 or omega-amidase, is involved in cellular metabolism of asparagine, glutamine, and oxaloacetate and is found in the cytosol and centrosome[5]. Structurally, NIT2 has a four-layered α/β/β/α fold typical of nitrilase enzymes and features a catalytic triad consisting of glutamate, lysine, and cysteine residues[1][3]. Although the physiological substrates and specific inhibitors of NIT2 are not well defined, some studies suggest distinct biological functions, including a role in cell growth regulation and possible tumor suppression[1]. NIT2 is considered an enzyme target, with roles in intermediary metabolism and the innate immune system. Currently, there are no established drugs or biomarkers directly associated with NIT2, and detailed clinical or safety data are lacking.
Enzymatic hydrolysis of carbon-nitrogen bonds (omega-amidase activity)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nitrilase family member 2 (NIT2).